Propanc Biopharma (PPCB US)

Propanc Biopharma, Inc. is a development-stage healthcare company focused on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. Its lead product candidate, PRP, is a novel formulation involving pro-enzymes, which are the inactive precursors of enzymes.